{"title": "Circulars & Directives", "author": "Lisa Assakina", "url": "https://www.npra.gov.my/index.php/en/informationen/general-information/circulars.html", "hostname": "npra.gov.my", "description": "{loadmodule mod_aridatatables,Circulars & Directives All}", "sitename": "npra.gov.my", "date": "2023-07-06", "cleaned_text": "Document (DRGD) Third Edition, Revision July 2023](https://www.npra.gov.my/index.php/en/directive-general/1527511-direktif-untuk-penggunaan-drug-registration-guidance-document-drgd-third-edition-fifth-revision-july-2023.html) Document (DRGD) Third Edition, January 2023](https://www.npra.gov.my/index.php/en/directive-general/1527460-direktif-untuk-penggunaan-drug-registration-guidance-document-drgd-third-edition-fourth-revision-january-2023.html) on the Acceptance Criteria for Quantification by Input (QBI) of Active Ingredients Claimed on Label of Traditional Medicine and Health Supplement (TMHS) Products](https://www.npra.gov.my/index.php/en/directive-general/1527424-direktif-berkenaan-pelaksanaan-garis-panduan-guidance-on-the-acceptance-criteria-for-quantification-by-input-qbi-of-active-ingredients-claimed-on-label-of-traditional-medicine-and-health-supplement-tmhs-products.html) Document (DRGD) Third Edition, Revision July 2022](https://www.npra.gov.my/index.php/en/directive-general/1527382-direktif-untuk-penggunaan-drug-registration-guidance-document-drgd-third-edition-third-revision-july-2022.html) |27-Jul-22 | | |[Pelaksanaan Projek |10-Jun-22 | Document (DRGD) Third Edition, January 2022](https://www.npra.gov.my/index.php/en/component/content/article/82-english/announcement-main/1527301-direktif-untuk-penggunaan-drug-registration-guidance-document-drgd-third-edition-second-revision-january-2022.html?Itemid=1391) : (i) Malaysian Guidelines on Good Pharmacovigilance Practices (GVP) For Product Registration Holders, First Edition August 2021 (ii) Adverse Drug Reaction (ADR) / Adverse Event Following Immunisation (AEFI) Reporting Manual For Document (DRGD) Third Edition, Medicinal Gases](https://www.npra.gov.my/index.php/en/component/content/article/82-english/announcement-main/1527196-direktif-berkenaan-pengukuhan-pelaksanaan-kawalan-regulatori-ke-atas-produk-produk-gas-perubatan-dan-penggunaan-guideline-on-registration-of-medicinal-gases.html?Itemid=1391) |11-Feb-21 | | |[Direktif Untuk Penggunaan Drug Registration Guidance Untuk Penggunaan Drug Registration Guidance Document (DRGD) Second Edition, September 2016, Revised Jan 2020](/images/2020/Direktif_Bil_1_2020_DRGD.pdf) Drug Registration Guidance Document (DRGD) Second Edition, September 2016, Revised July 2019](/images/2019/07/Direktif-15_2019-DIREKTIF-UNTUK-PENGGUNAAN-DRGD-2ND-EDITION-REVISED-JULY-2019.pdf) side effects (tendinitis, tendon peripheral neuropathy & side effects (tendinitis, tendon peripheral neuropathy & dan Major Variation kepada Minor Variation (Notification)* Do Untuk Penggunaan Drug Registration Guidance Document (DRGD) Second Edition, September 2016, Revised January 2019](/images/Circulars_Directive/Regulatory_Information/2019/Direktif_Penggunaan_DRGD_Second_Edition_September_2016_Revised_January_2019.pdf) |[Direktif untuk melaksanakan guidelines on conditional registration for New Chemical |27-Feb-18 | | |[Direktif Untuk Penggunaan Drug Registration Guidance Document (DRGD) Second Edition, September 2016, Revised January 2018](/images/Circulars_Directive/Regulatory_Information/2018/DirektifDRGDJan2018.pdf) Tarikh Pelaksanaan Guideline Drug-Medical menguatkuasakan penggunaan Guidance Document and Guidelines for Registration of Cell and Gene Therapy Products (CGTPs), December 2015 dan Good Tissue Practice Guideline, 2nd edition, December 2015.](/images/Circulars_Directive/Regulatory_Information/2017/Bil_6_2017.pdf) Tahun 2017 Edition - |23-Mar-17 | | |[Direktif Untuk Menguatkuasakan Guidance Document Second Edition September 2016 ](/images/Guidelines_Central/guideline-DRGD/Direktif_Penggunaan_Drug_Registration_Guidance_Document_Second_Edition_September_2016.pdf) |30-Aug-16 | | |[Direktif Untuk Melaksanakan Malaysian Variation Guideline for Natural (Traditional Medicine & Homeopathy) and Health Supplement Products (Abridged Evaluation)](/images/Circulars_Directive/Regulatory_Information/2016/160727_Direktif_Bil14_2016.pdf) |26-Jul-16 Direktif untuk menguatkuasakan penggunaan Guidance Document and Guidelines for Registration of Cell and Gene Therapy Products (CGTPs), December 2015 dan Good Tissue Practice Guideline, 2nd edition, December 2015](/images/Circulars_Directive/Regulatory_Information/2016/160310_CGTP_Circular.pdf) |10-Mar-16 |29-Jun-16 Malaysia](/images/Circulars_Directive/Regulatory_Information/Direktif%20Pelaksanaan%20VLR.pdf) |14-Jan-15 | | |[Invitation To The 23rd Asean Consultative Committee For Standards And Quality (ACCSQ) ](/images/Circulars_Directive/Regulatory_Information/Invitation%20To%20The%2023rd%20Asean%20Consultative%20Committee%20For%20Standards%20And%20Quality%20(ACCSQ)%20Traditional%20Medicines%20Health%20Supplements%20(TMHS)%20And%20Its%20Related%20Meetings%20From.pdf) Traditional Medicines Health Supplements (TMHS) And Its Related Meetings From 1-5th June 2015, Kuala Variation Guideline for Pharmaceutical Products 2013 (First Edition)](/images/Circulars_Directive/Regulatory_Information/page-7/Malaysia-Variation-Guideline-for-Pharmaceutical-Products-2013_edition-1April2013-080513.pdf) | | | |[Direktif Malaysian on How to Use Consumer Medication Information Leaflets (RiMUP)](/images/Circulars_Directive/Regulatory_Information/page-7/Website-Appendix-1-Eng-210513.pdf) | | | |[Pelaksanaan 'Increased Risk For Opportunistic Infections Such As Activation of Latent Viral Infections Including BK Virus - Associated 'Potential for an the symptomatic relief of pain and inflammation in patients with osteoarthritis, rheumatoid arthritis and Associated with Concomitant Use of Ceftriaxone with Calcium Containing Solution |13-Sep-07 | Sleep - Related Behaviors Which May Include Sleep Driving, Making Phone Calls, Preparing and Eating Food (While Asleep) |30-Aug-07 | | |[Bil (74) dlm in Marketing Authorization Holder of a Registered Product) |28-Nov-05 | | |[Bil By The Drug Control Authority' |27-Jan-05 Tapak Pengilangan](/images/Circulars_Directive/Bioequivalence_BE/Bil-31-dlm-1.pdf) |13-May-09 | | |[Bioequivalence Study for Generic, Immediate Release, Oral, Solid Dosage Form Submitted as a Second Source - 2 Jun 2011](/images/Circulars_Directive/Bioequivalence_BE/BE_second_source_2011-1.pdf) |2-Jun-11 | | |[Bil (10) dlm BPFK/PPP/01/03 Jld 1 (All generic, immediate release, oral, solid, dosage form containing scheduled poison) - 2 Mac 2011](/images/Circulars_Directive/Bioequivalence_BE/Direktif_Pusat_kajian_BE_1-1.pdf) |2-Mar-11 | | |[Bil(8)dlm BPFK/PPP/01/03 Jld 1 Mac 2004](/images/Circulars_Directive/Bioequivalence_BE/5thBil85.pdf) |18-Mar-04 | | |[Bil(85)dlm BPFK/007/3.8 (4th list) - 14 Jun 2002](/images/Circulars_Directive/Bioequivalence_BE/4thBil85.pdf) |14-Jun-02 | | |[Bil(50)dlm BPFK/007.3.8 (3rd list) - 8 Mei 2001](/images/Circulars_Directive/Bioequivalence_BE/3rdBil50.pdf) |8-May-01 | |[Bil(85)dlm BPFK/007.3.7 (2nd 2000](/images/Circulars_Directive/Bioequivalence_BE/2ndBil85.pdf) |14-Feb-00 BPFK/007/3.7 Dalam Annex Control Of Cosmetic ](/images/Circulars_Directive/Cosmetic/2018/PEKELILINGBIL32018.pdf) Cosmetic Products In Malaysia- 1st Revision, February 2017 (3 |[ Products on Its Profile](/images/Circulars_Directive/Safety_Updates/Maklumat%20Keselamatan%20Strontium%20Ranelate_27012014.pdf%20new.pdf) |27-Jan-14 | | |[ Hydroxy-E Starch (HES) Products: with Severe Renal Impairment and Increased Mortality.(Follow-up Communication)](/images/Circulars_Directive/Safety_Updates/MAKLUMAT%20KESELAMATAN%20%20SUSULAN%20HES_20012014.pdf) |20-Jan-14 | | |[ Erythropoetin Stimulating Agents Pure Red Register (NMRR)](/images/Circulars_Directive/Clinical_Trial/Arahan_keperluan%20mendaftar%20penyelidikan%20klinikal%20yang%20melibatkan%20ubatan%20dengan%20nmrr.pdf) |23-Sep-13 | | |[Directive on Requirement for Registration of Clinical Trials with | "}